-
Article
Efficacy and Safety Outcomes for Originator TNF Inhibitors and Biosimilars in Rheumatoid Arthritis and Psoriasis Trials: A Systematic Literature Review
Regulatory approval of biosimilar versions of originator biotherapeutics requires that new biological products be highly similar to originator products, with no clinically meaningful differences in safety, pur...
-
Article
Open AccessBiosimilar Drugs for Psoriasis: Principles, Present, and Near Future
Psoriasis is a chronic, inflammatory, lifelong disease with a high prevalence (afflicting approximately 1–5% of the population worldwide) and is associated with significant morbidity. The introduction of biolo...
-
Article
Open AccessThe Language of Biosimilars: Clarification, Definitions, and Regulatory Aspects
Biologic therapies have revolutionized treatment of a number of diseases. Patents and exclusivity for a number of biologics are expiring. This has created the opportunity for the development and approval of bi...
-
Article
Open AccessMonoclonal Antibody and Fusion Protein Biosimilars Across Therapeutic Areas: A Systematic Review of Published Evidence
Despite regulatory efforts to formalize guidance policies on biosimilars, there remains a need to educate healthcare stakeholders on the acknowledged definition of biosimilarity and the data that underpin it.
-
Article
Open AccessBiosimilars for the Treatment of Chronic Inflammatory Diseases: A Systematic Review of Published Evidence
Clinicians are required to assimilate, critically evaluate, and extrapolate information to support appropriate use of biosimilars across indications.
-
Article
Open AccessSurvey of physician experiences and perceptions about the diagnosis and treatment of fibromyalgia
Fibromyalgia (FM) is a condition characterized by widespread pain and is estimated to affect 0.5-5% of the general population. Historically, it has been classified as a rheumatologic disorder, but patients con...
-
Article
Open AccessA patient survey of the impact of fibromyalgia and the journey to diagnosis
Fibromyalgia is a painful, debilitating illness with a prevalence of 0.5-5.0% that affects women more than men. It has been shown that the diagnosis of fibromyalgia is associated with improved patient satisfac...
